By Pishtaz | 2026-04-28

The Islamic Republic has triggered a cascading "domino effect" that now restricts its population’s access to life-saving medicines across disrupted supply chains.

By closing national airspace and destabilizing regional transit hubs, authorities have severely undermined the logistics networks required to deliver critical pharmaceutical supplies.

Air cargo paralysis has emerged as the most immediate consequence, crippling the primary system used to transport temperature-sensitive and high-value medical products.

The International Air Transport Association notes that air freight carries a significant share of time-critical pharmaceutical shipments worldwide.

With Iranian airspace closed and regional hubs affected, essential delivery routes for cold-chain medicines have been severely restricted or entirely disrupted.

Alternative routes exist but introduce delays that undermine the viability of sensitive pharmaceutical products requiring strict temperature controls during transit.

Shipments rerouted through distant hubs or extended maritime detours can add weeks, increasing the risk of spoilage before reaching patients.

The World Health Organization (WHO) warns improper temperature control can render medicines ineffective or unsafe, particularly for insulin and cancer therapies.

Costs have simultaneously surged across the supply chain, compounding access challenges already facing patients dependent on timely pharmaceutical delivery systems.

Escalating Gulf tensions have also sharply increased maritime insurance premiums and disrupted critical shipping flows.

These rising logistics costs are passed directly to consumers, driving significant price increases for essential goods and limiting affordability nationwide.

Compounding the crisis, domestic pharmaceutical production faces mounting pressure from restricted access to petrochemical inputs required for manufacturing generic medicines.